FASLG and Livedo reticularis: In another study examining the clinical features of aPL-positive patients participating in the APS Alliance for Clinical Trials and International Networking (APS ACTION), cardiac valve involvement was found in 10%, thrombocytopenia in 19% and livedo reticularis/racemosa in 14%.